SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
SEC Accession No. 0001144204-17-014995
Filing Date
2017-03-16
Accepted
2017-03-16 12:10:41
Documents
1
Period of Report
2016-12-31
Effectiveness Date
2017-03-16

Document Format Files

Seq Description Document Type Size
1 NOTIFICATION OF LATE FILING v461959_nt10k.htm NT 10-K 24003
  Complete submission text file 0001144204-17-014995.txt   25163
Mailing Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017
Business Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-K | Act: 34 | File No.: 001-35076 | Film No.: 17693587
SIC: 2835 In Vitro & In Vivo Diagnostic Substances